Oral hyposensitization to nickel induces clinical improvement and a decrease in TH1 and TH2 cytokines in patients with systemic nickel allergy syndrome.
Minelli M, Schiavino D, Musca F, Bruno ME, Falagiani P, Mistrello G, Riva G, Braga M, Turi MC, Di Rienzo V, et al. Int J Immunopathol Pharmacol. 2010 Jan-Mar; 23(1):193-201.